<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Targeting cystatin F activation enhances NK cell cytotoxicity in glioblastoma models</dc:title><dc:creator>Senjor,	Emanuela	(Avtor)
	</dc:creator><dc:creator>Habič,	Anamarija	(Avtor)
	</dc:creator><dc:creator>Švajger,	Urban	(Avtor)
	</dc:creator><dc:creator>Mitrović,	Ana	(Avtor)
	</dc:creator><dc:creator>Proj,	Matic	(Avtor)
	</dc:creator><dc:creator>Porčnik,	Andrej	(Avtor)
	</dc:creator><dc:creator>Prestor,	Borut	(Avtor)
	</dc:creator><dc:creator>Jerala,	Miha	(Avtor)
	</dc:creator><dc:creator>Bošnjak,	Matic	(Avtor)
	</dc:creator><dc:creator>Gobec,	Stanislav	(Avtor)
	</dc:creator><dc:creator>Breznik,	Barbara	(Avtor)
	</dc:creator><dc:creator>Kos,	Janko	(Avtor)
	</dc:creator><dc:creator>Perišić,	Milica	(Avtor)
	</dc:creator><dc:subject>glioblastoma</dc:subject><dc:subject>cystatin F</dc:subject><dc:subject>3D models</dc:subject><dc:description>Introduction: Glioblastoma (GBM) is a highly invasive brain tumor with limited treatment options and poor prognosis. Natural killer (NK) cells are key effectors of antitumor immunity, capable of eliminating cancer stem-like cells. However, GBM creates an immunosuppressive microenvironment that limits NK cell function. Here, we identify cystatin F as an immunosuppressive factor involved in regulating NK cell granule-mediated cytotoxicity. Methods: We analyzed cystatin F expression in GBM and its correlation with immune exhaustion markers. NK cell activity was compared between GBM patients and healthy donors. In vitro co-cultures of cystatin F-expressing microglial cells and glioblastoma stem-like cells were used to assess NK cell function. To block cystatin F activation from dimeric to active monomeric form, a small-molecule inhibitor of cathepsin V, the activating protease, was applied. Results: Cystatin F expression correlated with immune exhaustion and suppression markers in GBM. NK cells from patients showed reduced cytotoxicity compared to healthy donors. Co-cultures confirmed that cystatin F-expressing microglia impaired NK cell cytotoxicity, while inhibition of cathepsin V restored NK cell function in standard cytotoxicity assays, 3D spheroids, and microfluidic perfused models. Discussion: These results indicate that cystatin F mediates NK cell suppression in GBM. Targeting its activation enhances NK cell cytotoxicity, offering a potential strategy to improve NK-based immunotherapy for glioblastoma.</dc:description><dc:date>2025</dc:date><dc:date>2025-11-26 09:56:19</dc:date><dc:type>Neznano</dc:type><dc:identifier>24363</dc:identifier><dc:identifier>UDK: 577</dc:identifier><dc:identifier>ISSN pri članku: 1664-3224</dc:identifier><dc:identifier>DOI: 10.3389/fimmu.2025.1708281</dc:identifier><dc:identifier>COBISS_ID: 258230275</dc:identifier><dc:language>sl</dc:language></metadata>
